文献速递骨软组织肉瘤与黑色素瘤

TEM1/内皮唾液酸蛋白介导的人肉瘤靶向治疗

Tumour endothelial marker 1/endosialin-mediated targeting of human sarcoma.
PubMed 文献 · Eur J Cancer · 2018-01-04

该研究分析了203例人肉瘤标本中TEM1的表达,并验证了抗TEM1单链抗体融合蛋白78Fc的体内靶向能力,以及其与皂草毒蛋白偶联物78Fc-Sap在体外和体内对人肉瘤的杀伤效果。结果显示TEM1在96%的人肉瘤中表达,78Fc-Sap能有效杀伤TEM1+肉瘤细胞并消除移植瘤而无明显毒性。

要点

  • TEM1在96%的人肉瘤中表达,81%同时表达于肿瘤细胞和血管。
  • 78Fc可特异性靶向TEM1+肉瘤移植瘤。
  • 78Fc-Sap在体外和体内均有效杀伤TEM1+肉瘤,无明显毒性。

核心结论

  • TEM1是人肉瘤的重要治疗靶点,高亲和力TEM1特异性scFv融合蛋白78Fc适合进一步临床开发用于肉瘤治疗。

研究设计与样本

  • 研究收集2000至2015年宾夕法尼亚大学医院临床肉瘤标本,经标准福尔马林固定石蜡包埋处理,分析19种人肉瘤亚型(n=203例标本)和8种人肉瘤细胞系中TEM1的表达。
  • 采用荷瘤小鼠近红外成像验证78Fc与TEM1+肉瘤的体内结合,并测试抗TEM1 78Fc与皂草毒蛋白偶联物(78Fc-Sap)在体外和体内对人肉瘤的治疗效果。

主要发现

  • 免疫组化显示96%的人肉瘤表达TEM1,其中81%在肿瘤细胞和肿瘤血管上均表达TEM1。
  • 近红外成像显示标记的78Fc在体内特异性靶向TEM1+肉瘤移植瘤。
  • 78Fc-Sap在体外有效杀伤TEM1+肉瘤细胞,并在体内消除人肉瘤移植瘤而无明显毒性。

临床怎么用

  • TEM1可作为人肉瘤治疗的潜在靶点,78Fc-Sap偶联物值得进一步临床开发。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Tumour endothelial marker 1 (TEM1/endosialin/CD248) is a tumour-restricted cell-surface protein expressed by human sarcomas. We previously developed a high-affinity human single-chain variable fragment (scFv)-Fc fusion protein (78Fc) against TEM1 and demonstrated its specific binding to human and mouse TEM1. PATIENT AND METHODS: Clinical sarcoma specimens were collected between 2000 and 2015 at the Hospital of the University of Pennsylvania, as approved by the institutional review board and processed by standard formalin-fixed paraffin embedded techniques. We analysed TEM1 expression in 19 human sarcoma subtypes (n = 203 specimens) and eight human sarcoma-cell lines. Near-infrared (NIR) imaging of tumour-bearing mice was used to validate 78Fc binding to TEM1+ sarcoma in vivo. Finally, we tested an immunotoxin conjugate of anti-TEM1 78Fc with saporin (78Fc-Sap) for its therapeutic efficacy against human sarcoma in vitro and in vivo. RESULTS: TEM1 expression was identified by immunohistochemistry in 96% of human sarcomas, of which 81% expressed TEM1 both on tumour cells and the tumour vasculature. NIR imaging revealed specific in vivo targeting of labelled 78Fc to TEM1+ sarcoma xenografts. Importantly, 78Fc-Sap was effective in killing in vitro TEM1+ sarcoma cells and eliminated human sarcoma xenografts without apparent toxicity in vivo. CONCLUSION: TEM1 is an important therapeutic target for human sarcoma, and the high-affinity TEM1-specific scFv fusion protein 78Fc is suitable for further clinical development for therapeutic applications in sarcoma.

来源:Eur J Cancer,查看原文。版权归原作者所有。

引用

  1. Guo Y, Hu J, Wang Y, et al. Tumour endothelial marker 1/endosialin-mediated targeting of human sarcoma. Eur J Cancer. 2018. PMID: 29304474. doi:10.1016/j.ejca.2017.10.035

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。